In the latest trading session, 4.18 million Bristol-Myers Squibb Co. (NYSE:BMY) shares changed hands as the company’s beta touched 0.46. With the company’s most recent per share price at $52.20 changing hands around $0.46 or 0.89% at last look, the market valuation stands at $105.83B. BMY’s current price is a discount, trading about -11.23% off its 52-week high of $58.06. The share price had its 52-week low at $39.35, which suggests the last value was 24.62% up since then. When we look at Bristol-Myers Squibb Co.’s average trading volume, we note the 10-day average is 14.1 million shares, with the 3-month average coming to 13.64 million.
Analysts gave the Bristol-Myers Squibb Co. (BMY) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.86. If we narrow down to specifics, the data shows that 0 out of 14 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 9 recommended BMY as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Bristol-Myers Squibb Co.’s EPS for the current quarter is expected to be 1.59.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bristol-Myers Squibb Co. (NYSE:BMY) trade information
Instantly BMY is in green as seen in intraday trades today. With action 2.47%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 1.73%, with the 5-day performance at 2.47% in the green. However, in the 30-day time frame, Bristol-Myers Squibb Co. (NYSE:BMY) is 4.50% up. Looking at the short shares, we see there were 21.79 million shares sold at short interest cover period of 2.28 days.
The consensus price target for the stock as assigned by Wall Street analysts is 66.5, meaning bulls need an upside of 21.5% from its recent market value. According to analyst projections, BMY’s forecast low is 41 with 85 as the target high. To hit the forecast high, the stock’s price needs a -62.84% plunge from its current level, while the stock would need to tank 21.46% for it to hit the projected low.
Bristol-Myers Squibb Co. (BMY) estimates and forecasts
Year-over-year growth is forecast to reach 11.30% up from the last financial year.
Consensus estimates given by 16 financial analysts project the company’s revenue in the current quarter to hit an average of 11.3B. 15 analysts are of the opinion that Bristol-Myers Squibb Co.’s revenue for the current quarter will be 11.48B. The company’s revenue for the corresponding quarters a year ago was 9.99B and 10.72B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 13.10%. The estimates for the next quarter sales put growth at 7.10%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 5.14%. The 2024 estimates are for Bristol-Myers Squibb Co. earnings to decrease by -90.05%, but the outlook for the next 5-year period is at -4.81% per year.
BMY Dividends
Bristol-Myers Squibb Co. is expected to release its next quarterly earnings report on 2024-Oct-31. The 4.54% annual yield figure for the share gives it an annual dividend of 2.37. It is important to note, however, that the 4.54% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 3.39 per year.
Bristol-Myers Squibb Co. (NYSE:BMY)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.11% of Bristol-Myers Squibb Co. shares while 77.93% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 78.02%. There are 77.93% institutions holding the Bristol-Myers Squibb Co. stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.2225% of the shares, roughly 186.57 million BMY shares worth $7.75 billion.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.8428% or 158.66 million shares worth $6.59 billion as of 2024-06-30.
